LD-V1 demonstrates suitability for low-dose MV measurements and exhibits improved low-dose sensitivity relative to EBT4, indicating its potential value for MLC QA in highly dynamic treatment deliveries. Nonetheless, its pronounced energy and scanning-orientation dependence underscores the need for rigorous and consistent calibration and handling procedures.
Edmondson et al. (Wed,) studied this question.